Erythrocyte patch for enhanced B cell depletion therapy
Open Access
- 22 May 2026
- journal article
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (21) , eaed3138
Abstract
Dysregulated B cells are central to many hematologic malignancies and autoimmune diseases, but current B cell–targeted therapies often fail to translate binding into effective signaling. Here, we present CD20 EryPatch, a living dynamic cellular patch that co-opts natural erythrocyte processes of morphological and biological changes, enabling a dual mechanism of micrometer-scale mechanotransduction and phagocytic “tag-and-clear” for enhanced B cell depletion. CD20 EryPatches are designed to adhere to B cells and anchor on CD20 receptors across extensive cell surface areas. Their progressive discocyte-to-echinocyte transition provides deformability-driven traction, enabling localized, large-scale CD20 cross-linking that amplifies downstream apoptosis in target B cells. Concomitant biomarker alteration on CD20 EryPatch converts it into an “eat me” tag attached to the B cell, facilitating further clearance by initiating erythrophagocytosis. This approach proves more effective than standard CD20 monoclonal antibodies in models of B cell disorders, including non-Hodgkin lymphoma, systemic lupus erythematosus, and rheumatoid arthritis.Keywords
Funding Information
- National Natural Science Foundation of China (82373818)
- Science and Technology Department of Sichuan Province (2026NSFSC0564)
- National Key Research and Development Program of China (2024YFA1210100)
This publication has 46 references indexed in Scilit:
- A Two-Step Pretargeted Nanotherapy for CD20 Crosslinking May Achieve Superior Anti-Lymphoma Efficacy to RituximabTheranostics, 2015
- Multifunctional Theranostic Red Blood Cells For Magnetic‐Field‐Enhanced in vivo Combination Therapy of CancerAdvanced Materials, 2014
- Cell Surface Self-Assembly of Hybrid Nanoconjugates via Oligonucleotide Hybridization Induces ApoptosisACS Nano, 2013
- Non-Hodgkin lymphomaThe Lancet, 2012
- The future of anti-CD20 monoclonal antibodies: are we making progress?Blood, 2011
- Collagen-induced arthritisNature Protocols, 2007
- B-cell targeting in rheumatoid arthritis and other autoimmune diseasesNature Reviews Immunology, 2006
- Synthetic Multivalent Ligands as Probes of Signal TransductionAngewandte Chemie International Edition, 2006
- Enhancement of susceptibility of CB-17 mice to systemic candidiasis by poly(I . C)-induced interferonInfection and Immunity, 1993
- Murine Models of Systemic Lupus Erythematosus1985